Paradigm Biopharmaceuticals Ltd
ASX:PAR
Shareholder Yield
Current shareholder yield for 
SKO is
-0.41%.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
PAR Price
Paradigm Biopharmaceuticals Ltd
| Average Annual Return | -15.77% |
| Standard Deviation of Annual Returns | 50.51% |
| Max Drawdown | -95% |
| Market Capitalization | 128.5m AUD |
| Shares Outstanding | 389 430 000 |
| Percentage of Shares Shorted |
N/A
|
Stock Splits
PAR's latest stock split occurred on Nov 1, 2023
The company executed a 1353-for-1316 stock split, meaning that for every 1316 shares held, investors received 1353 new shares.
Before the split, PAR traded at 0.5982 per share. Afterward, the share price was about 0.415.
The adjusted shares began trading on Nov 1, 2023. This was PAR's 3rd stock split, following the previous one in Aug 17, 2022.
You don't have any saved screeners yet
